Bafna Pharmaceuticals Limited has informed the Exchange regarding Proceedings of 30th Annual General Meeting of the Company held on September 19, 2025.
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has informed the stock exchange about the proceedings of its 30th Annual General Meeting held on September 19, 2025. This is a routine regulatory filing required after every AGM, where shareholders review company performance and vote on resolutions. The headline does not specify which resolutions were passed or any key business decisions taken at the meeting. Detailed voting results and any major announcements from the AGM are typically filed separately by the company. Investors should look for the full AGM proceedings document for specifics on approvals like financial statements, dividend, and board appointments.
This is a standard compliance disclosure with no direct material impact on the stock price. Shareholders should check the detailed voting results filing to see outcomes on key items such as dividend declaration, director appointments, and auditor ratification.